ID

31686

Descripción

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC); ODM derived from: https://clinicaltrials.gov/show/NCT01326559 Collaborating Parties: The University of Hong Kong Sanofi Merck Sharp & Dohme Corp. Roche Pharma AG

Link

https://clinicaltrials.gov/show/NCT01326559

Palabras clave

Versiones (2)
  1. 16.09.18 16.09.18 -
  2. 21.09.18 21.09.18 -
Titular de derechos de autor

Hong Kong Nasopharyngeal Cancer Study Group Limited

Subido en

21. September 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Nasopharyngeal Carcinoma NCT01326559

Inglés

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
recurrent t3n0-n1m0 npc (by ajcc/uicc 6th edition) and at least 1 year from the end of last primary course of radiotherapy
Descripción

AJCC Stage and recent radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0441915
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0262926
age > 18 to < 70 years
Descripción

Age group

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
performance status: < 1 by ecog system (appendix i)
Descripción

ECOG Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow & renal function
Descripción

Bone marrow and renal function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232804
patients having bilirubin =< 1.5 x uln, asat & alst=< 1.5 x uln, serum creatinine=< 1.25 x uln and / or creatinine clearance >= 60ml/min
Descripción

Bilirubin, AST, ALT, Creatinine and/or Creatinine clearance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201976
UMLS CUI [5]
C0373595
patients having wbc >= 3x10e9/l, neutrophils 1.8x10e9/l, platelets >= 100 x10e9/l,hemoglobin >=10g/dl
Descripción

WBC, neutrophils, platelet count, hemoglobin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
signed written informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
patients must have at least one measurable lesion
Descripción

One measurable lesion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C1513040
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of investigational agent within the past 28 days
Descripción

Recent use of investigational agent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0332185
pre-treatment with an anti-egfr drug
Descripción

Anti-egfr pre-treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1443775
UMLS CUI [1,2]
C1514463
UMLS CUI [2,1]
C4055105
UMLS CUI [2,2]
C1514463
severe cardiac disease such as heart failure, coronary artery disease or myocardial infarction within the last 12 months
Descripción

Svere cardiac disease, heart failure, CAD or recent myocardial infarction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0018801
UMLS CUI [3]
C1956346
UMLS CUI [4,1]
C0027051
UMLS CUI [4,2]
C4086728
history of severe pulmonary diseases
Descripción

Respiratory comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C0205082
active infection or other systemic disease under poor control
Descripción

Uncontrolled systemic disease or infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
uncontrolled chronic neuropathy
Descripción

Uncontrolled chronic neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C0205318
know grade 3 or 4 allergic reaction to any of the components of the treatment
Descripción

Drug allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1875319
estimated life expectancy is less than 3 months
Descripción

Life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
pregnancy or breast feeding
Descripción

Pregnancy or breast feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
AJCC Stage and recent radiotherapy
Item
recurrent t3n0-n1m0 npc (by ajcc/uicc 6th edition) and at least 1 year from the end of last primary course of radiotherapy
boolean
C0441915 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
Age group
Item
age > 18 to < 70 years
boolean
C0001779 (UMLS CUI [1])
ECOG Status
Item
performance status: < 1 by ecog system (appendix i)
boolean
C1520224 (UMLS CUI [1])
Bone marrow and renal function
Item
adequate bone marrow & renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
Bilirubin, AST, ALT, Creatinine and/or Creatinine clearance
Item
patients having bilirubin =< 1.5 x uln, asat & alst=< 1.5 x uln, serum creatinine=< 1.25 x uln and / or creatinine clearance >= 60ml/min
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0373595 (UMLS CUI [5])
WBC, neutrophils, platelet count, hemoglobin
Item
patients having wbc >= 3x10e9/l, neutrophils 1.8x10e9/l, platelets >= 100 x10e9/l,hemoglobin >=10g/dl
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Informed consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
One measurable lesion
Item
patients must have at least one measurable lesion
boolean
C0237753 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Recent use of investigational agent
Item
use of investigational agent within the past 28 days
boolean
C0013230 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Anti-egfr pre-treatment
Item
pre-treatment with an anti-egfr drug
boolean
C1443775 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C4055105 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Svere cardiac disease, heart failure, CAD or recent myocardial infarction
Item
severe cardiac disease such as heart failure, coronary artery disease or myocardial infarction within the last 12 months
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018801 (UMLS CUI [2])
C1956346 (UMLS CUI [3])
C0027051 (UMLS CUI [4,1])
C4086728 (UMLS CUI [4,2])
Respiratory comorbidity
Item
history of severe pulmonary diseases
boolean
C0024115 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Uncontrolled systemic disease or infection
Item
active infection or other systemic disease under poor control
boolean
C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Uncontrolled chronic neuropathy
Item
uncontrolled chronic neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Drug allergy
Item
know grade 3 or 4 allergic reaction to any of the components of the treatment
boolean
C0013182 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1875319 (UMLS CUI [1,3])
Life expectancy
Item
estimated life expectancy is less than 3 months
boolean
C0023671 (UMLS CUI [1])
Pregnancy or breast feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial